Cargando…

Oral immunotherapy combined with omalizumab for high–risk cow’s milk allergy: a randomized controlled trial

We evaluated the efficacy and safety of oral immunotherapy (OIT) combined with 24 weeks of omalizumab (OMB) at inducing desensitization in children with cow’s milk allergy (CM) compared with an untreated group. The present study was a prospective randomized controlled trial. Sixteen patients (age, 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Takahashi, Masaya, Soejima, Kazuhiko, Taniuchi, Shoichiro, Hatano, Yasuko, Yamanouchi, Sohsaku, Ishikawa, Hideki, Irahara, Makoto, Sasaki, Youhei, Kido, Hiroshi, Kaneko, Kazunari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5727171/
https://www.ncbi.nlm.nih.gov/pubmed/29234055
http://dx.doi.org/10.1038/s41598-017-16730-6